Buist H - Search Results

1

European Food Safety Authority (EFSA); Buist H, Craig P, Dewhurst I, Hougaard Bennekou S, Kneuer C, Machera K, Pieper C, Court Marques D, Guillot G, Ruffo F, Chiusolo A. European Food Safety Authority (EFSA), et al. Among authors: buist h. EFSA J. 2017 Jun 30;15(6):e04873. doi: 10.2903/j.efsa.2017.4873. eCollection 2017 Jun. EFSA J. 2017. PMID: 32625532 Free PMC article.

2

Relative absorption and dermal loading of chemical substances: Consequences for risk assessment.

Buist HE, Schaafsma G, van de Sandt JJ. Buist HE, et al. Regul Toxicol Pharmacol. 2009 Aug;54(3):221-8. doi: 10.1016/j.yrtph.2009.04.002. Epub 2009 Apr 22. Regul Toxicol Pharmacol. 2009. PMID: 19393281 Review.

3

New in vitro dermal absorption database and the prediction of dermal absorption under finite conditions for risk assessment purposes.

Buist HE, van Burgsteden JA, Freidig AP, Maas WJ, van de Sandt JJ. Buist HE, et al. Regul Toxicol Pharmacol. 2010 Jul-Aug;57(2-3):200-9. doi: 10.1016/j.yrtph.2010.02.008. Epub 2010 Feb 21. Regul Toxicol Pharmacol. 2010. PMID: 20178823

4

Effects of single and repeated exposure to biocidal active substances on the barrier function of the skin in vitro.

Buist HE, van de Sandt JJ, van Burgsteden JA, de Heer C. Buist HE, et al. Regul Toxicol Pharmacol. 2005 Oct;43(1):76-84. doi: 10.1016/j.yrtph.2005.06.006. Regul Toxicol Pharmacol. 2005. PMID: 16099566

5

Dermatokinetics of didecyldimethylammonium chloride and the influence of some commercial biocidal formulations on its dermal absorption in vitro.

Buist HE, de Heer C, van Burgsteden JA, van de Sandt JJ. Buist HE, et al. Regul Toxicol Pharmacol. 2007 Jun;48(1):87-92. doi: 10.1016/j.yrtph.2007.01.007. Epub 2007 Feb 4. Regul Toxicol Pharmacol. 2007. PMID: 17367906

6

The OSIRIS Weight of Evidence approach: ITS mutagenicity and ITS carcinogenicity.

Buist H, Aldenberg T, Batke M, Escher S, Klein Entink R, Kühne R, Marquart H, Pauné E, Rorije E, Schüürmann G, Kroese D. Buist H, et al. Regul Toxicol Pharmacol. 2013 Nov;67(2):170-81. doi: 10.1016/j.yrtph.2013.01.002. Epub 2013 Jan 26. Regul Toxicol Pharmacol. 2013. PMID: 23357514

7

A TTC threshold for acute oral exposure to non-genotoxic substances.

Buist HE, Krul L, Leeman WR. Buist HE, et al. Regul Toxicol Pharmacol. 2016 Apr;76:217-20. doi: 10.1016/j.yrtph.2016.01.022. Epub 2016 Feb 4. Regul Toxicol Pharmacol. 2016. PMID: 26853733

8

Hazard assessment of nitrosamine and nitramine by-products of amine-based CCS: alternative approaches.

Buist HE, Devito S, Goldbohm RA, Stierum RH, Venhorst J, Kroese ED. Buist HE, et al. Regul Toxicol Pharmacol. 2015 Apr;71(3):601-23. doi: 10.1016/j.yrtph.2014.01.017. Epub 2015 Jan 17. Regul Toxicol Pharmacol. 2015. PMID: 25604881 Review.

9

Derivation of the minimal magnitude of the Critical Effect Size for continuous toxicological parameters from within-animal variation in control group data.

Buist HE, von Bölcsházy GF, Dammann M, Telman J, Rennen MA. Buist HE, et al. Regul Toxicol Pharmacol. 2009 Nov;55(2):139-50. doi: 10.1016/j.yrtph.2009.06.009. Epub 2009 Jun 24. Regul Toxicol Pharmacol. 2009. PMID: 19559065

10

Predicting blood:air partition coefficients using basic physicochemical properties.

Buist HE, Wit-Bos Ld, Bouwman T, Vaes WH. Buist HE, et al. Regul Toxicol Pharmacol. 2012 Feb;62(1):23-8. doi: 10.1016/j.yrtph.2011.11.019. Epub 2011 Dec 9. Regul Toxicol Pharmacol. 2012. PMID: 22178169

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

119 results

Search Page

Filters